Bowling Portfolio Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Bowling Portfolio Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-145,512	Closed	-$308K	–	400
2016 Q4	$308K	Sell	145,512 -18,893	-11%	-$52.7K	0.05%	280
2016 Q3	$551K	Buy	164,405 +141,170	+608%	+$448K	0.08%	207
2016 Q2	$73K	Buy	23,235 +12,523	+117%	+$41.8K	0.01%	158
2016 Q1	$36K	Sell	10,712 -15,797	-60%	-$49.2K	0.01%	170
2015 Q4	$94K	Buy	+26,509	New	+$111K	0.02%	164
2015 Q2	–	Sell	-18,268	Closed	-$129K	–	175
2015 Q1	$129K	Buy	18,268 +5,437	+42%	+$39.4K	0.03%	142
2014 Q4	$99K	Buy	+12,831	New	+$102K	0.02%	138

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bowling Portfolio Management's PDLI Position: Q1 2017 in Review

Bowling Portfolio Management sold out of PDL BioPharma, Inc. (PDLI) in Q1 2017, closing a stake of 145,512 shares — an estimated $308K sold.

Bowling Portfolio Management first reported a position in PDLI in Q4 2014 and held it in 7 quarters. The position peaked at $551K in Q3 2016. 174 funds tracked by Wall St. Rank hold PDLI as of Q1 2017.

Bowling Portfolio Management reported no remaining PDL BioPharma, Inc. position as of Q1 2017 after selling out during the quarter.
Bowling Portfolio Management sold 145,512 PDL BioPharma, Inc. shares in Q1 2017, an estimated $308K.
Bowling Portfolio Management first reported a position in PDL BioPharma, Inc. in Q4 2014 and held it in 7 quarters.
Bowling Portfolio Management's PDL BioPharma, Inc. position peaked at $551K in Q3 2016.
174 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2017.

Based on Bowling Portfolio Management's 13F filing for Q1 2017, filed 1 May 2017.